Live Quote · OTCRADCQHealthcare· Medical - Pharmaceuticals

Rite Aid Corporation

$0.01 376.19%(+$0.01)
TickerSpark Score
41/100
Weak
73
Valuation
45
Profitability
15
Growth
40
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RADCQ research report →

52-Week Range1% of range
Low
$0.00
Current
$0.01
High
$0.96
Company Overviewwww.riteaid.com

About the company

Rite Aid Corporation, operating through its various subsidiary entities, manages an extensive chain of retail pharmacies throughout the United States. The company's operations are divided into two main divisions: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment is primarily involved in dispensing both generic and branded prescription medications.

CEO
Jeffrey Scott Stein
IPO
1980
Employees
47,000
HQ
Philadelphia, PA, US

Price Chart

-73.68% · this period
$0.04$0.02$0.00Sep 01Mar 05Sep 03
Valuation
Market Cap
$559.74K
P/E
-0.05
P/S
0.00
P/B
-0.06
EV/EBITDA
-183.71
Div Yield
0.00%
Profitability
Gross Margin
19.94%
Op Margin
-0.41%
Net Margin
-3.11%
ROE
276.35%
ROIC
-1.83%
Growth & Income
Revenue
$24.09B · -1.94%
Net Income
$-719,188,000 · -37.68%
EPS
$-13.15 · -36.13%
Op Income
$64.36M
FCF YoY
-289.28%
Performance & Tape
52W High
$0.96
52W Low
$0.00
50D MA
$0.03
200D MA
$0.13
Beta
1.26
Avg Volume
28.74K

Get TickerSpark's AI analysis on RADCQ

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · RADCQ

Our RADCQ coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on RADCQ yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate RADCQ report →
Internal Compare

Similar companies

Peers in the same neighborhood.